In:
British Journal of Psychiatry, Royal College of Psychiatrists, Vol. 169, No. S31 ( 1996-12), p. 31-40
Kurzfassung:
A recent challenge in schizophrenia has been the management of patients who have failed to respond not only to standard therapeutic regimes but also to trials of atypical neuroleptics such as clozapine and risperidone. This article focuses on the further psychological and pharmacological management of such patients.
Materialart:
Online-Ressource
ISSN:
0007-1250
,
1472-1465
DOI:
10.1192/S0007125000298590
Sprache:
Englisch
Verlag:
Royal College of Psychiatrists
Publikationsdatum:
1996
ZDB Id:
2021500-9